NCT07112547

Brief Summary

Cardiovascular diseases are the leading cause of death worldwide. Among them, coronary artery disease-especially in its acute form, known as acute coronary syndrome (ACS)-is the most frequent cause of cardiovascular death. There are two main types of ACS: ST-segment elevation myocardial infarction (STEMI) and non-ST-segment elevation ACS (NSTE-ACS). While the occurrence of serious heart rhythm and conduction disturbances is well established in STEMI, these complications are believed to be much less frequent in NSTE-ACS. However, their actual frequency in this population remains unclear due to limited studies, especially in emergency settings. The main purpose of this study is to estimate the frequency of serious rhythm and conduction disorders in patients presenting with NSTE-ACS in emergency departments. The hypothesis is that these events are rare in this population and may not justify routine continuous cardiac monitoring for all such patients, as currently recommended. Secondary objectives include identifying risk factors for these complications, estimating their frequency during hospitalization, assessing the frequency of minor rhythm and conduction disorders, evaluating care times and patient flow in emergency departments, and assessing patient outcomes up to 30 days-including hospitalizations, length of stay, discharge disposition, all-cause mortality, and the occurrence of five major adverse cardiovascular events (5-point MACE).

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
500

participants targeted

Target at P75+ for all trials

Timeline
30mo left

Started Sep 2025

Typical duration for all trials

Geographic Reach
1 country

10 active sites

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress22%
Sep 2025Oct 2028

First Submitted

Initial submission to the registry

May 27, 2025

Completed
2 months until next milestone

First Posted

Study publicly available on registry

August 8, 2025

Completed
24 days until next milestone

Study Start

First participant enrolled

September 1, 2025

Completed
3.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2028

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2028

Last Updated

August 8, 2025

Status Verified

August 1, 2025

Enrollment Period

3.1 years

First QC Date

May 27, 2025

Last Update Submit

August 1, 2025

Conditions

Keywords

Non-ST Segment Elevation Acute Coronary SyndromeCardiac ArrhythmiasHeart Conduction System DiseaseHospital Emergency ServiceElectrocardiographic monitoringCardiovascular diseases

Outcome Measures

Primary Outcomes (1)

  • Occurrence of Serious Rhythm or Conduction Disturbances in the Emergency Department

    Occurrence of at least one serious rhythm or conduction disturbance during emergency department management, including: sustained ventricular tachycardia (VT), ventricular fibrillation (VF), torsades de pointes, high-degree conduction disorders (Mobitz type II AV block, third-degree AV block, trifascicular block), pulseless electrical activity (PEA), and asystole.

    During emergency department stay, assessed up to 24 hours

Secondary Outcomes (24)

  • Incidence of Non-Life-Threatening Arrhythmias or Conduction Disorders in the Emergency Department

    During emergency department stay, assessed up to 24 hours

  • Number of patients presenting complications prior to a confirmed diagnosis of NSTE-ACS

    Prior to establishing a confirmed diagnosis of NSTE-ACS in the ED, assessed up to 12 hours

  • Duration of Stay in the Emergency Department

    From ED admission to hospital admission, discharge, or UHCD discharge; up to 72 hours

  • Number of patients by disposition at emergency department discharge (home vs. hospital admission and type of admitting service

    At the time of emergency department discharge or transfer, assessed up to 72 hours from ED admission

  • Duration of Hospitalization

    From hospital admission to hospital discharge, assessed up to 14 days.

  • +19 more secondary outcomes

Study Arms (1)

Non-ST segment elevation ACS

500 adult patients admitted to the emergency department and diagnosed with non-ST segment elevation ACS

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Adult patients admitted to the emergency department and diagnosed with non-ST segment elevation ACS

You may qualify if:

  • Adult (≥ 18 years old) patient admitted to the emergency department
  • Able to understand the information provided
  • Diagnosis of non-ST segment elevation ACS established according to the lastest guidelines from the European Society of Cardiology and the 4th Universal Definition of myocardial infarction
  • No objection to participation in the study after receiving appropriate information

You may not qualify if:

  • Patients subject to legal protection
  • Patient with cognitive impairment
  • Myocardial injury and/or symptoms attributable to Takotsubo syndrome, myocarditis, pericarditis, or acute heart failure
  • Clinical evidence suggestive of type 2 myocardial infarction, including acute anemia with hemoglobin \< 10 g/dL, sepsis, acute hypoxemic respiratory failure

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (10)

Centre Hospitalier de Haguenau

Haguenau, Bas-Rhin, 67091, France

Location

Centre Hospitalier de Sélestat

Séléstat, Bas-Rhin, 67606, France

Location

Hôpitaux Universitaires de Strasbourg (NHC)

Strasbourg, Bas-Rhin, 67091, France

Location

Hôpital Louis Pasteur

Colmar, Haut-rhin, 68024, France

Location

Hôpital Emilie Muller

Mulhouse, Haut-rhin, 68100, France

Location

Hôpital Maison Blanche

Reims, Marne, 51092, France

Location

CHRU de Nancy

Nancy, Meurthe-et-Moselle, 54000, France

Location

Centre Hospitalier de Pont-à-Mousson

Pont-à-Mousson, Meurthe-et-Moselle, 54701, France

Location

Centre Hospitalier de Toul Saint-Charles

Toul, Meurthe-et-Moselle, 54200, France

Location

CHU de Poitiers, la Milétrie

Poitiers, Vienne, 86000, France

Location

Related Publications (6)

  • Bouisset F, Ruidavets JB, Dallongeville J, Moitry M, Montaye M, Biasch K, Ferrieres J. Comparison of Short- and Long-Term Prognosis between ST-Elevation and Non-ST-Elevation Myocardial Infarction. J Clin Med. 2021 Jan 7;10(2):180. doi: 10.3390/jcm10020180.

    PMID: 33430516BACKGROUND
  • Pines JM, Pollack CV Jr, Diercks DB, Chang AM, Shofer FS, Hollander JE. The association between emergency department crowding and adverse cardiovascular outcomes in patients with chest pain. Acad Emerg Med. 2009 Jul;16(7):617-25. doi: 10.1111/j.1553-2712.2009.00456.x. Epub 2009 Jun 22.

    PMID: 19549010BACKGROUND
  • Timmis A, Vardas P, Townsend N, Torbica A, Katus H, De Smedt D, Gale CP, Maggioni AP, Petersen SE, Huculeci R, Kazakiewicz D, de Benito Rubio V, Ignatiuk B, Raisi-Estabragh Z, Pawlak A, Karagiannidis E, Treskes R, Gaita D, Beltrame JF, McConnachie A, Bardinet I, Graham I, Flather M, Elliott P, Mossialos EA, Weidinger F, Achenbach S; Atlas Writing Group, European Society of Cardiology. European Society of Cardiology: cardiovascular disease statistics 2021. Eur Heart J. 2022 Feb 22;43(8):716-799. doi: 10.1093/eurheartj/ehab892.

    PMID: 35016208BACKGROUND
  • Thygesen K, Alpert JS, Jaffe AS, Chaitman BR, Bax JJ, Morrow DA, White HD; Executive Group on behalf of the Joint European Society of Cardiology (ESC)/American College of Cardiology (ACC)/American Heart Association (AHA)/World Heart Federation (WHF) Task Force for the Universal Definition of Myocardial Infarction. Fourth Universal Definition of Myocardial Infarction (2018). Glob Heart. 2018 Dec;13(4):305-338. doi: 10.1016/j.gheart.2018.08.004. Epub 2018 Aug 25. No abstract available.

    PMID: 30154043BACKGROUND
  • Byrne RA, Rossello X, Coughlan JJ, Barbato E, Berry C, Chieffo A, Claeys MJ, Dan GA, Dweck MR, Galbraith M, Gilard M, Hinterbuchner L, Jankowska EA, Juni P, Kimura T, Kunadian V, Leosdottir M, Lorusso R, Pedretti RFE, Rigopoulos AG, Rubini Gimenez M, Thiele H, Vranckx P, Wassmann S, Wenger NK, Ibanez B; ESC Scientific Document Group. 2023 ESC Guidelines for the management of acute coronary syndromes. Eur Heart J. 2023 Oct 12;44(38):3720-3826. doi: 10.1093/eurheartj/ehad191. No abstract available.

    PMID: 37622654BACKGROUND
  • Collet JP, Thiele H, Barbato E, Barthelemy O, Bauersachs J, Bhatt DL, Dendale P, Dorobantu M, Edvardsen T, Folliguet T, Gale CP, Gilard M, Jobs A, Juni P, Lambrinou E, Lewis BS, Mehilli J, Meliga E, Merkely B, Mueller C, Roffi M, Rutten FH, Sibbing D, Siontis GCM; ESC Scientific Document Group. 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Rev Esp Cardiol (Engl Ed). 2021 Jun;74(6):544. doi: 10.1016/j.rec.2021.05.002. No abstract available. English, Spanish.

    PMID: 34020768BACKGROUND

MeSH Terms

Conditions

Acute Coronary SyndromeMyocardial InfarctionAngina, UnstableDeath, Sudden, CardiacStrokePeripheral Arterial DiseaseArrhythmias, CardiacEmergenciesCardiovascular Diseases

Condition Hierarchy (Ancestors)

Myocardial IschemiaHeart DiseasesVascular DiseasesInfarctionIschemiaPathologic ProcessesPathological Conditions, Signs and SymptomsNecrosisAngina PectorisChest PainPainNeurologic ManifestationsSigns and SymptomsHeart ArrestDeath, SuddenDeathCerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesAtherosclerosisArteriosclerosisArterial Occlusive DiseasesPeripheral Vascular DiseasesDisease Attributes

Study Officials

  • Sabrina GARNIER-KEPKA, Dr

    Hôpitaux Universitaires de Strasbourg

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 27, 2025

First Posted

August 8, 2025

Study Start

September 1, 2025

Primary Completion (Estimated)

October 1, 2028

Study Completion (Estimated)

October 1, 2028

Last Updated

August 8, 2025

Record last verified: 2025-08

Locations